IGHE and cancer: However, no elevation in the levels of such mediators, including IL-4, IL-5, IL-6 and IL-8, following treatment with antitumour IgE in in vitro and in vivo models of cancer has been measured to date [32,67] and the number of these cells in the TME is significantly lower compared to monocytes/macrophages.